RESUMEN
BACKGROUND: Achievement of lipid targets is crucial in patients with type 2 diabetes mellitus (T2DM) to mitigate the risk of cardiovascular diseases (CVD). Data on lipid-control status among patients with T2DM in Bangladesh are scarce. This study was conducted to determine the lipid-control status among patients with T2DM who were on lipid-lowering drugs in the country. METHODS: This cross-sectional study was conducted in the diabetes outpatient departments of several tertiary hospitals in Bangladesh from January 2022 to December 2022. Adults of both sexes diagnosed with T2DM for at least one year and were on the lipid-lowering drug(s) for a minimum of 3 months were included in the study by consecutive sampling. Patients' data were collected by face-to-face interviews, and blood samples were collected for fasting lipid profile. The lipid target was set at < 200 mg/dL for total cholesterol (TC), < 150 mg/dL for triglyceride (TG), < 100 mg/dL for low-density lipoprotein cholesterol (LDL-C), > 40 mg/dL for high-density lipoprotein cholesterol (HDL-C), and < 160 mg/dL for non-HDL cholesterol (non-HDL-C). RESULT: Three thousand sixty patients (age 44.7 ± 13.3 years, female 57%) with T2DM were evaluated. Overall, almost 81% of the study subjects achieved the LDL-C target. Besides, TC, TG, HDL-C, and non-HDL-C targets were achieved by 40.8, 21.6, 66.3, and 44.1% of patients, respectively. However, all the lipid parameters were under control in only 8.8% of patients. Almost 77.6% of the patients with ischemic heart disease, 81.5% of patients with stroke, and 65% of patients with CKD had LDL levels < 70 mg/dL. Only 10.03% achieved the HbA1c target of < 7%. 7.4% of patients achieved both HbA1c < 7% and LDL < 100 mg/dL and 5% achieved both HbA1c < 7% and LDL < 70 mg/dL. Advanced age (aOR 0.97, 95% CI 0.96, 0.98, p < 0.001), longstanding T2DM (aOR 0.53, 95% CI 0.39, 0.72, p < 0.001), and non-statin therapy (aOR 0.25, 95% CI 0.16, 0.37, p < 0.001) were negatively associated with lipid control (LDL < 100 mg/dL) while using oral hypoglycemic drugs or insulin (aOR 2.01, 95% CI 1.45, 2.77, p < 0.001) and having cardiovascular comorbidity (aOR 3.92, 95% CI 3.00, 5.12, p < 0.001) were positively associated with lipid control. CONCLUSION: Though most patients with T2DM achieved their target LDL level, the prevalence of both glycemic and overall lipid control was low in our study despite lipid-lowering therapy.
Asunto(s)
Diabetes Mellitus Tipo 2 , Dislipidemias , Masculino , Adulto , Humanos , Femenino , Persona de Mediana Edad , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diabetes Mellitus Tipo 2/epidemiología , Estudios Transversales , LDL-Colesterol , Hemoglobina Glucada , HDL-Colesterol , TriglicéridosRESUMEN
This study investigates the effectiveness of kaolin and bentonite catalysts in improving liquid hydrocarbon yields during the pyrolysis of waste tires. Raw clay, nitric acid-treated clay, and mono- or bimetal-impregnated clay were used as catalysts in the pyrolysis of waste tire. Acid-treated kaolin produced a higher yield of liquid hydrocarbons (43.24-47%) compared to acid-treated bentonite (35.34-41.85%). This improvement in the liquid yield can be attributed to the higher specific surface area and pore diameter of the acid-treated clay in comparison to raw kaolin (39.48%) and raw bentonite (31.62%). Moreover, the use of metal-impregnated catalysts, such as Fe/kaolin and Ni/Fe/kaolin, resulted in higher liquid yields (47%) compared to the 3 M HNO3-treated kaolin catalyst (43.24%). Gas chromatography-mass spectrometry (GC-MS) analysis confirmed the presence of limonene, a crucial ingredient for commercial perfume production, in the liquid products. The calorific values of oil obtained through kaolin and bentonite catalysis were measured at 13,922 and 10,174 kcal/kg, respectively, further highlighting the potential of these catalysts in waste tire valorization.
RESUMEN
The polycrystalline Li0.15Ni0.6-xZnxCu0.1Fe2.15O4 ferrites are fabricated by the method of conventional solid-state reaction technique. The X-ray diffraction (XRD) confirms that the structure of the composition is a single-phase cubic spinel structure for all samples. The particle size of the compositions is varied from 36 to 52 nm. The lattice parameter and densities are found to increase with enhancing Zn content, as the ionic radius and atomic weight of Zn are greater than Ni. The porosity exhibits a decreasing trend. The average grain size determined using Field Emission Scanning Microscopy (FESEM) increases until x = 0.40, then declines. The Energy-Dispersive Spectroscopy (EDS) examination revealed that the percentage of obtained elements is well matched with the stoichiometric elements. The addition of Zn content acts as an accelerator for enhancing the value of the real part of initial permeability and the highest value is obtained (µi' = 276) for the x = 0.40 sample, as well as the highest relative quality factor (RQF) of around 3000. The loss factor for the Zn substituted composition is nine times lower than for the parent composition. The optimum saturation magnetization of around 77.49 emu/g is found for the x = 0.40 sample. The maximum dielectric constant (ε' = 2.85 × 103) is found for x = 0.10 samples at 10 kHz. Further, from impedance studies, the non-Debye type dielectric relaxation is seen for the Zn-substituted samples. The observed region of the imaginary electric modulus peak signifies the transition of charge carrier mobility from a larger range to a short-range distance. The phenomenon of ac conductivity is attributed to the process of the small polaron hopping mechanism.